首页|PLGA-Tf纳米递药系统合成及防滥用性能评价

PLGA-Tf纳米递药系统合成及防滥用性能评价

扫码查看
目的 探讨转铁蛋白(Tf)修饰的聚乳酸-羟基乙酸共聚物(PLGA)作为药物递送系统负载芬太尼结构类似物阿拉斯汀的制备条件,并评估纳米制剂的体外稳定性、生物相容性及防滥用性能。方法 采用分步合成法合成PLGA-Tf@Era,考察PLGA-Tf与阿拉斯汀的质量比对粒径和聚合物分散性指数(PDI)的影响。采用透射电子显微镜检测PLGA-Tf@Era的形貌,采用马尔文激光粒度仪检测粒径,采用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳银染试验进行结构表征。体外检测PLGA-Tf@Era 7 d内在不同介质[水、磷酸盐缓冲液(PBS)、胎牛血清(FBS)、RPMI-1640培养基]中的稳定性,在乙醇和酸性水溶液(pH 5。1)中的提取率,以及25,50,100,200,400 μg/mL PLGA-Tf@Era溶血的发生情况。结果 制备PLGA-Tf@Era的最优条件为PLGA-Tf与阿拉斯汀的质量比为10:1,平均粒径为122 nm,包封率为82。20%,载药量为14。82%。结构表征试验结果显示,Tf和阿拉斯汀成功装载。透射电子显微镜检查结果显示,PLGA-Tf@Era形态规整,呈圆球形或类球形,分散性良好,无团聚现象。体外检测结果显示,PLGA-Tf@Era7d内在不同介质(水、PBS、FBS、RPMI-1640培养基)中的粒径和PDI均无明显变化,能维持形态不变;给药浓度低于100 μg/mL时的溶血发生率较低,生物安全性较好;PLGA-Tf@Era在酸性水溶液(pH 5。1)和乙醇中提取12 h后的提取率仍低于21%。结论 合成的PLGA-Tf@Era粒径适宜、载药量高、性能稳定,可用于防止芬太尼类药物的滥用。
Synthesis and Anti-Abuse Performance Evaluation of PLGA-Tf Nano Drug Delivery System
Objective To investigate the preparation conditions of transferrin(Tf)-modified poly(lactic-co-glycolic acid)copolymer(PLGA)as a drug delivery system loaded with fentanyl analogues erastin,and to evaluate the stability,biocompatibility,and abuse-deterrent properties of the nanosystem in vitro.Methods The PLGA-Tf@Era was synthesized by the stepwise synthesis method.The effect of the mass ratio of PLGA-Tf to erastin on particle size and polydispersity index(PDI)was investigated.The morphology of PLGA-Tf@Era was detected by transmission electron microscopy.The particle size was detected by the Malvern laser particle size analyzer,and the structure was characterized by the sodium dodecyl sulfate-polyacrylamide gel electrophoresis silver staining test.The stability of PLGA-Tf@Era in different media[water,phosphate-buffered saline(PBS),fetal bovine serum(FBS),RPMI-1640 medium]within 7 d was detected in vitro,the extraction rate in ethanol and acidic aqueous solution(pH 5.1)and the incidence of hemolysis of 25,50,100 200,400 μg/mL PLGA-Tf@Era were detected.Results The optimal preparation conditions for PLGA-Tf@Era were as follows:the mass ratio of PLGA-Tf to erastin was 10∶1,the average particle size was 122 nm,the encapsulation efficiency was 82.20%,and the drug loading was 14.82%.The structural characterization test results showed that Tf and erastin were successfully loaded.Transmission electron microscopy examination results showed that PLGA-Tf@Era had a regular morphology,appearing spherical or quasi-spherical,with good dispersibility and no agglomeration phenomenon.The in vitro test results showed that the particle size and PDI of PLGA-Tf@Era in different media(water,PBS,FBS,RPMI-1640 medium)did not show significant changes within 7 d,and the morphology remained unchanged.When the drug concentration was below 100 μg/mL,the incidence of hemolysis was low,and the biological safety was good.The extraction rate of PLGA-Tf@Era was still lower than 21%after 12 h of extraction in the acidic aqueous solution(pH 5.1)and ethanol.Conclusion The synthesized PLGA-Tf@Era has suitable particle size,high drug loading capacity,and stable performance,which can be used to prevent the abuse of fentanyl-like drugs.

poly(lactic-co-glycolic acid)copolymertransferrinerastinhemolysis ratein vitro stabilityanti-abuse

田金明、谢莉、唐华、彭金林、朱小康、陈竹

展开 >

西南大学药学院,重庆 400716

重庆市食品药品检验检测研究院·国家药品监督管理局麻醉精神药品质量监测重点实验室,重庆 401121

聚乳酸-羟基乙酸共聚物 转铁蛋白 阿拉斯汀 溶血率 体外稳定性 防滥用

重庆市科学技术局科研机构绩效激励引导专项项目国家药品监督管理局麻醉精神药品质量监测重点实验室开放课题

cstc2022jxjl120003NPKF-2021-03

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(17)